It was previously reported that TGFβ signaling pathways are involved in multiple aspects of CRC progression; we hypothesized that the low expression of several genes in this pathway, such as TGFβRII, and SMAD2 in CRC, could be due to the up-regulation of miRNAs that target this pathway. This evidence concerns the gene SMAD2 and colorectal carcinoma.